FOSL1 as a candidate target gene for 11 q 12 rearrangements in desmoplastic fibroblastoma

Laboratory Investigation

Volumn 92, Issue 5, 2012, Pages 735-743

  MacChia, Gemma ^a,b   Trombetta, Domenico ^a,b,c   Möller, Emely ^a   Mertens, Fredrik ^a   Storlazzi, Clelia T ^b   Debiec Rychter, Maria ^d   Sciot, Raf ^d   Nord, Karolin H ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF BARI   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

11q12; APC; CTNNB1; Desmoid tumor; Desmoplastic fibroblastoma; FOSL1

Indexed keywords

APC PROTEIN; PROTEIN; PROTEIN FOSL1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOME 11Q; CHROMOSOME BAND; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CYTOGENETICS; DESMOPLASTIC FIBROBLASTOMA; FEMALE; FIBROMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE LOCUS; GENE TARGETING; GENETIC ASSOCIATION; HEMIZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METAPHASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; AGED; BETA CATENIN; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 5; CYTOGENETIC ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GARDNER SYNDROME; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MUSCLE TISSUE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-FOS; TRANSLOCATION, GENETIC;

EID: 84860290499     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.46     Document Type: Article

References (33)

1. Maghari A, Ma N, Aisner S, et al. Collagenous fibroma (desmoplastic fibroblastoma) with a new translocation involving 11q12: a case report. Cancer Genet Cytogenet 2009;192:73-75.
2. Evans HL. Desmoplastic fibroblastoma. A report of seven cases. Am J Surg Pathol 1995;19:1077-1081.
3. Sciot R, Samson I, van den Berghe H, et al. Collagenous fibroma (desmoplastic fibroblastoma): genetic link with fibroma of tendon sheath? Mod Pathol 1999;12:565-568. (Pubitemid 29279707)
4. Bernal K, Nelson M, Neff JR, et al. Translocation (2;11)(q31;q12) is recurrent in collagenous fibroma (desmoplastic fibroblastoma). Cancer Genet Cytogenet 2004;149:161-163. (Pubitemid 38293033)
5. Sakamoto A, Yamamoto H, Yoshida T, et al. Desmoplastic fibroblastoma (collagenous fibroma) with a specific breakpoint of 11q12. Histopathology 2007;51:859-860. (Pubitemid 350179402)
6. Dal Cin P, Sciot R, De Smet L, et al. Translocation 2;11 in a fibroma of tendon sheath. Histopathology 1998;32:433-435. (Pubitemid 28231376)
7. Singh NG, Mannan AASR, Kahvic M. Desmoplastic fibroblastoma (collagenous fibroma): report of a case. Indian J Pathol Microbiol 2011;54:206-207.
8. Fletcher CDM, Unni KK, Mertens F, (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press: Lyon, 2002.
9. Shaffer LG, Slovak ML, Campbell LJ. An International System for Human Cytogenetic Nomenclature (2009). Karger: Basel, 2009.
10. Jin Y, Mö ller E, Nord KH, et al. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes. Genes Chromosomes Cancer 2012; Epub ahead of print.
11. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet 2004;36:949-951. (Pubitemid 39167488)
12. Möller E, Hornick JL, Magnusson L, et al. FUS-CREB3L2/L1-positive sarcomas show a specific gene expression profile with upregulation of CD24 and FOXL1. Clin Cancer Res 2011;17:2646-2656.
13. Saeed AI, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003; 34:374-378. (Pubitemid 36184095)
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001;25:402-408. (Pubitemid 34164012)
15. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36.
16. Kasper B, Ströbel P, Hohenberger P. Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist 2011;16: 682-693.
17. Cools J, Mentens N, Odero MD, et al. Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13). Blood 2002; 99:1776-1784. (Pubitemid 34533053)
18. Einerson RR, Law ME, Blair HE, et al. Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2. Leukemia 2006;20:1790-1799. (Pubitemid 44574990)
19. Hallor KH, Sciot R, Staaf J, et al. Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions. J Pathol 2009;217:716-727.
20. Young MR, Colburn NH. Fra-1 a target for cancer prevention or intervention. Gene 2006;379:1-11. (Pubitemid 44247331)
21. Robinson MJ, Stippec SA, Goldsmith E, et al. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol 1998;8:1141-1150. (Pubitemid 28494712)
22. Bergers G, Graninger P, Braselmann S, et al. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol Cell Biol 1995;15:3748-3758.
23. Hamada F, Bienz M. The APC tumor suppressor binds to C-terminal binding protein to divert nuclear-catenin from TCF. Dev Cell 2004;7:677-685. (Pubitemid 39462688)
24. Mann B, Gelos M, Siedow A, et al. Target genes of b-catenin-T cellfactor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 1999;96:1603-1608. (Pubitemid 29098498)
25. Wang HL, Wang J, Xiao SY, et al. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing - catenin. Int J Cancer 2002;101: 301-310. (Pubitemid 34983184)
26. Alman BA, Li C, Pajerski ME, et al. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 1997;151:329-334. (Pubitemid 27330053)
27. Li C, Bapat B, Alman BA. Adenomatous polyposis coli gene mutation alters proliferation through its b-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol 1998;153: 709-714. (Pubitemid 28419025)
28. Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 1999;18:6615-6620.
29. Cheon SS, Cheah AYL, Turley S, et al. b-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci USA 2002;99:6973-6978. (Pubitemid 34526242)
30. Miettinen M, Fetsch JF. Collagenous fibroma (desmoplastic fibroblastoma): a clinicopathologic analysis of 63 cases of a distinctive soft tissue lesion with stellate-shaped fibroblasts. Hum Pathol 1998;29:676-682. (Pubitemid 28322051)
31. Coffin CM, Hornick JL, Zhou H, et al. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas. Am J Surg Pathol 2007;31:410-416. (Pubitemid 46673115)
32. Lanckohr C, Debiec-Rychter M, Müller O, et al. Gardner fibroma: case report and discussion of a new soft tissue tumor entity. Pathologe 2002;31:97-105.
33. Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res 2002;12:996-1006. (Pubitemid 34662293)